$1.3
Cellectar Biosciences is a biotechnology business based in the US. Cellectar Biosciences shares (CLRB) are listed on the NASDAQ and all prices are listed in US Dollars. Cellectar Biosciences employs 15 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy Cellectar Biosciences stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – CLRB. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
SoFi Invest
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 in stock when you fund a new account within 30 days
eToro
- Easy to use platform with $0 stock trading & no annual fees
- Social trading allows you to copy popular portfolios
- FINDER EXCLUSIVE: Guaranteed $15 bonus when you sign up and deposit $100
tastytrade
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+
Cellectar Biosciences stock price (NASDAQ: CLRB)
Use our graph to track the performance of CLRB stocks over time.Cellectar Biosciences shares at a glance
Latest market close | $2.10 |
---|---|
52-week range | $1.25 - $4.31 |
50-day moving average | $1.89 |
200-day moving average | $1.69 |
Wall St. target price | $12.60 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-3.18 |
Buy Cellectar Biosciences stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Is it a good time to buy Cellectar Biosciences stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Cellectar Biosciences price performance over time
Historical closes compared with the close of $2.1 from 2023-09-19
1 week (2023-09-14) | 3.45% |
---|---|
1 month (2023-08-21) | 27.27% |
3 months (2023-06-21) | 5.53% |
6 months (2023-03-21) | 37.25% |
1 year (2022-09-21) | -51.28% |
---|---|
2 years (2021-09-21) | 118.75% |
3 years (2020-09-21) | 76.47% |
5 years (2018-09-21) | 2.7 |
Cellectar Biosciences financials
Gross profit TTM | $0 |
---|---|
Return on assets TTM | -124.37% |
Return on equity TTM | -322.69% |
Profit margin | 0% |
Book value | $-0.19 |
Market Capitalization | $20.5 million |
TTM: trailing 12 months
Cellectar Biosciences share dividends
We're not expecting Cellectar Biosciences to pay a dividend over the next 12 months.
Have Cellectar Biosciences's shares ever split?
Cellectar Biosciences's shares were split on a 1:10 basis on 21 July 2022. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Cellectar Biosciences shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Cellectar Biosciences shares which in turn could have impacted Cellectar Biosciences's share price.
Cellectar Biosciences share price volatility
Over the last 12 months, Cellectar Biosciences's shares have ranged in value from as little as $1.25 up to $4.3112. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Cellectar Biosciences's is 1.3351. This would suggest that Cellectar Biosciences's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Cellectar Biosciences overview
Cellectar Biosciences, Inc. , a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study for patients with B-cell malignancies; Phase 2a clinical study for patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia cohort, r/r multiple myeloma (MM) cohort, and r/r non-Hodgkin's lymphoma cohort; Phase 1 clinical study for r/r pediatric patients with select solid tumors, lymphomas, and malignant brain tumors; and Phase 1 clinical study for r/r pediatric patients with head and neck cancer. The company also develops CLR 1900, a PDC chemotherapeutic program that is in the preclinical development stage to treat solid tumors. It has collaborative with Orano Med to develop CLR 12120 Series; and LegoChemBio. The company was founded in 2002 and is headquartered in Florham Park, New Jersey. .
Cellectar Biosciences in the news
Cellectar Biosciences Receives European Medicines Agency Priority Medicines (PRIME) Designation for Iopofosine for Waldenstrom’s Macroglobulinemia
Cellectar Biosciences Announces Closing of up to Approximately $103 Million Private Placement Financing
Cellectar Biosciences Announces up to Approximately $103 Million Private Placement Financing
Frequently asked questions
What percentage of Cellectar Biosciences is owned by insiders or institutions?Currently 5.157% of Cellectar Biosciences shares are held by insiders and 33.897% by institutions. How many people work for Cellectar Biosciences?
Latest data suggests 15 work at Cellectar Biosciences. When does the fiscal year end for Cellectar Biosciences?
Cellectar Biosciences's fiscal year ends in December. Where is Cellectar Biosciences based?
Cellectar Biosciences's address is: 100 Campus Drive, Florham Park, NJ, United States, 07932 What is Cellectar Biosciences's ISIN number?
Cellectar Biosciences's international securities identification number is: US15117F5008 What is Cellectar Biosciences's CUSIP number?
Cellectar Biosciences's Committee on Uniform Securities Identification Procedures number is: 67000M100
More guides on Finder
-
How to buy Discord stock when it goes public
Everything we know about the Discord IPO, plus information on how to buy in.
-
Today’s trending Reddit stocks
We’ve pulled a list together of the meme stocks being mentioned most on Reddit in the past 24 hours.
-
How to buy Tottenham Acquisition I stock
Steps to owning and managing TOTA, with 24-hour and historical pricing before you buy.
-
How to buy TotalEnergies stock
Steps to owning and managing TOT, with 24-hour and historical pricing before you buy.
-
How to buy Thunder Bridge Acquisition stock
Steps to owning and managing THBR, with 24-hour and historical pricing before you buy.
-
How to buy Switchback Energy Acquisition Corporation stock
Steps to owning and managing SBE, with 24-hour and historical pricing before you buy.
-
How to buy Telefonica SA ADR stock
Steps to owning and managing TEF, with 24-hour and historical pricing before you buy.
-
How to buy Faraday Future stock
Steps to owning and managing PSACU, with 24-hour and historical pricing before you buy.
-
How to buy Phoenix Tree stock
Steps to owning and managing DNK, with 24-hour and historical pricing before you buy.
-
How to buy Innate Pharma stock
Steps to owning and managing IPHA, with 24-hour and historical pricing before you buy.
Ask an Expert